The company leads the weight-loss drugs market with its blockbuster, Wegovy. But next-generation drugs are coming.

The post IBD Stock Of The Day Novo Nordisk: Why A Pullback Is Bullish For The Weight-Loss Kingpin appeared first on Investor’s Business Daily.